Your email has been successfully added to our mailing list.

×
-0.0246205059920107 -0.00159786950732369 -0.0252996005326232 -0.0279627163781625 0.0117177097203727 0.0117177097203727 0.0117177097203727 0.0117177097203727
Stock impact report

Vaxart Provides Merger Update

Atea Pharmaceuticals, Inc. - common stock (AVIR) 
Company Research Source: Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today it has reached an understanding with the CAS Group under which East Hill, a major shareholder in Aviragen, will support the merger between Vaxart and Aviragen. “We are committed to creating significant value for all our shareholders as evidenced by the amended terms of the merger that were recently announced,” said Wouter W. Latour, M.D., chief executive officer of Vaxart. “We want to thank all those who helped in that process, including in particular the current Vaxart shareholders.” “We look forward to building a long term relationship with East Hill, as with all our shareholders, and greatly appreciate their support.” About Vaxart Vaxart is a clinical-stage company focus Show less Read more
Impact Snapshot
Event Time:
AVIR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
AVIR alerts

from News Quantified
Opt-in for
AVIR alerts

from News Quantified